Navigation Links
Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
Date:4/14/2008

rate entity has the financial incentive to fund clinical research to definitively assess its potential. We believe it is our obligation to the PD community to step in where other funders may be unwilling to go, and ensure that innovative approaches like this one do not stall for lack of resources."

Inosine is widely available to consumers in dietary supplement form. The researchers emphasize that people with Parkinson's should not take inosine except in the context of a closely monitored clinical trial in which potential benefits and risks are carefully balanced. The evidence to date surrounding inosine and PD does not prove a cause-effect relationship. Additionally, elevated urate levels are known to carry certain health risks, only some of which have been definitively characterized to date. Kidney stones and gout are known risks; cardiovascular disease is a possible risk. (In the clinical trial, safety measures will be in place to help avoid these conditions, and to detect and treat them should they arise.)

LEAPS awards are multi-year, multi-million-dollar awards to teams of key experts who focus on answering major questions that can improve the diagnosis and treatment of Parkinson's disease. This third and final 2007 LEAPS award is the Foundation's single largest award to date. It brings the total funding under the 2007 LEAPS program to $13.8 million.

The principal investigators of this LEAPS award are:

-- Coordinating principal investigator Michael A. Schwarzschild, MD, PhD, of the MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, will oversee all elements of the trial.

-- Co-principal investigator Alberto Ascherio, MD, DrPH, of the Harvard School of Public Health, will assist in all aspects of trial design and data analysis and head the main biostatistician team.

-- Co-principal investigator Karl Kieburtz, MD, MPH, of the University of Rochester School of Medicine and Denti
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
2. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
3. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
4. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
5. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
6. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
7. Gates Foundation Seeks Proposals for Innovative Global Health Research
8. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
9. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
10. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
11. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... STAAR Surgical Company (NASDAQ: STAA ), ... and delivery systems for the eye, today announced that ... Roush , CPA to the Company,s Board. This appointment ... to seven.Mr. Roush brings an important combination of financial ... 39 year tenure as a Partner at PricewaterhouseCoopers, prior ...
(Date:4/21/2015)... and CAMBRIDGE, Mass. , April ... Tokyo : 4503) and Potenza Therapeutics, Inc., ... programs, today announced an exclusive research and development ... advance a portfolio consisting of programs with novel ... signals and regulatory T cells. The agreement includes ...
(Date:4/21/2015)... Calif. and TOKYO , ... international life science partnering conferences, has just announced ... for the innovative medical technology industry. The event, held ... be the first dedicated international medtech partnering conference in ... will provide insights into new developments in the rapidly ...
Breaking Medicine Technology:J. Steven Roush, CPA Appointed to STAAR Surgical Board of Directors 2J. Steven Roush, CPA Appointed to STAAR Surgical Board of Directors 3Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 2Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 3Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 2Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 3Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 4
... CHICAGO, June 04, 2007 /PRNewswire/ -- GlaxoSmithKline ... of pazopanib in,advanced or metastatic renal cell ... (STS). These trials were presented at the,43rd ... Clinical Oncology,(ASCO) in Chicago. The results observed ...
... /PRNewswire/ -- (SEND2PRESS,NEWSWIRE) -- Epeius Biotechnologies Corporation today ... oncology and a,definitive benchmark in the emerging field ... its kind, Le Morte du Tumour --,published in ... Vol.30, pp. 1297-1307 -- documents the histologic,features of ...
Cached Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
(Date:4/21/2015)... 2015 Edward Avalos, USDA Under Secretary ... former Secretary of the California Department of Food and ... 2nd Annual GrowRIVERSIDE Conference: The Future of Local Food, ... of these nationally known experts intensifies an already strong ... and others slated to speak at the June 11-13 ...
(Date:4/21/2015)... 21, 2015 Respected academic institution selects ... , Visage Imaging Inc. (“Visage”), a wholly owned ... signed a seven-year contract with University of Florida Health ... The deal furthers the penetration of Visage ... key area of the North American enterprise imaging market. ...
(Date:4/21/2015)... Wojo Nutrition announces Abe’s Market ... healthiest, will carry Wojo Nutrition's lines of single serving ... they’ve launched a revolution in the vitamin industry that ... their multifaceted goals. Their line of single serving liquid ... been specially formulated to be as unique as the ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Now ... & Exhibition is set to unite over 3,000 ... mobile communities at the Suburban Collection Showplace on ... automakers including Volvo, Nissan, Ford, and Kia are ... how the connected car is reshaping automotive as ...
(Date:4/21/2015)... April 21, 2015 Carinsuranceshoppingsource.com has ... analyzing comprehensive auto insurance plans . , ... provides coverage for numerous situations. The coverage limit can ... Comprehensive auto insurance will protect a car against fire ... , Comparing quotes is no longer difficult and it ...
Breaking Medicine News(10 mins):Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 3Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:Wojo Nutrition Announces their Lines of Single Serving Liquid Vitamins will be Available for Purchase online at Abesmarket.com Beginning in May 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 3Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2
... Jan. 22 SeQual Technologies Inc., a medical ... for their reliability, quality, and revolutionary design and ... (AWR) from the U.S. Army,s Research, Development, and ... The certification indicates that the Eclipse(R) Oxygen Concentrator ...
... of its Board of Directors, held today, Wyeth (NYSE: ... Preferred Stock of the Company.A dividend of thirty cents ($.30) ... declared payable on March 2, 2009 to stockholders of record ... In addition, a dividend of fifty cents ($.50) per share ...
... Turner Construction Company, the nation,s largest builder of ... million construction project at Children,s Hospital Central California in ... 59,531 sq. ft. addition to and a 17,306 sq. ... the expansion of the emergency and trauma departments, four ...
... Petitions to Congressman Obey,s OfficeWASHINGTON, Jan. 22 ... a petition with 45,000 signatures to ... and his Wisconsin district, urging him to use ... Committee to ensure that taxpayers are not forced ...
... Hospitals with more expertise handling these attacks also ... News) -- Brain hemorrhage patients have better outcomes ... handle many brain attack emergencies, according to updated ... Subarachnoid hemorrhage (SAH) occurs when a blood vessel ...
... free or nearly free events offered this Saturday, January 24 ... history-making celebration where yogis, novices, couch potatoes and triathletes, young, ... body and spirit through the practice of yoga is this ... of karma yoga, or service to others, all Yoga Day ...
Cached Medicine News:Health News:SeQual Technologies is Awarded the U.S. Army Airworthiness Certification 2Health News:New Brain Hemorrhage Guidelines Stress Quick Action 2Health News:Yoga Day USA Changes Lives and Builds Community 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: